Company Overview

Halo Collective Inc. is a cannabis company that historically operated across cultivation, manufacturing, distribution, and retail activities in the legal cannabis industry. The company focused on producing and distributing cannabis flower, oils, concentrates, edibles, and related products for medical and adult-use markets. Halo Collective operated through vertically integrated cannabis assets, with revenue historically generated from wholesale cannabis sales, branded consumer products, extraction services, and retail dispensary operations. Public disclosures and market reporting identified the company as active primarily in North America, with operations and investments extending into Europe and Africa during portions of its expansion strategy.

The company evolved through a series of acquisitions, restructurings, and international expansion initiatives following its formation as Halo Labs Inc., later rebranding to Halo Collective Inc. Strategic growth efforts included acquisitions of cultivation and retail assets, extraction infrastructure, and international cannabis licensing opportunities. Public filings and financial disclosures indicate the company experienced operational and financial challenges in later years, including restructuring efforts and asset rationalization. Some operational details vary across reporting periods due to changing corporate structure and divestitures.

Business Operations

Halo Collective historically organized its operations around cannabis cultivation, processing, extraction, manufacturing, distribution, and retail sales. Core business units included cannabis cultivation facilities, extraction laboratories, branded product manufacturing, and dispensary assets. The company operated or controlled several subsidiaries and cannabis-focused entities, including Halo Labs, Bophelo Bioscience & Wellness, and retail-related assets acquired through prior transactions. Revenue generation was tied primarily to cannabis product sales, bulk wholesale transactions, and branded retail distribution in regulated cannabis markets.

The company maintained operations and investments in both domestic and international markets at various points in its corporate development. In the United States, activities included cultivation and processing operations in states such as Oregon and California. Internationally, Halo Collective pursued cultivation and export opportunities through partnerships and investments in Lesotho and exploratory European market initiatives. Publicly available filings also referenced strategic supply agreements, licensing arrangements, and cross-border cannabis distribution ambitions, although the scale and continuity of certain operations became less clear in later reporting periods. Data regarding the current operational status of some subsidiaries is inconclusive based on available public sources.

Strategic Position & Investments

Halo Collective’s strategy centered on vertical integration, international cannabis cultivation capacity, and the development of branded cannabis consumer products. The company pursued expansion through acquisitions and investments intended to secure cultivation scale, extraction capabilities, and retail market access. Notable transactions included the acquisition of Cannafe, retail-related assets, and investments connected to Bophelo Bioscience & Wellness, a large-scale cannabis cultivation project in Lesotho designed to support international medical cannabis supply opportunities.

The company also sought exposure to emerging cannabis sectors including concentrates, derivative products, and international medical cannabis exports. Strategic communications and investor materials emphasized low-cost cultivation, extraction expertise, and cross-border cannabis distribution potential. However, subsequent financial filings and restructuring disclosures suggested that several growth initiatives encountered execution and financing pressures. Publicly available records indicate that Halo Collective undertook restructuring measures and asset sales as part of broader efforts to stabilize operations and manage liabilities.

Geographic Footprint

Halo Collective maintained a multinational operational and investment footprint during its expansion phase. The company was headquartered in Canada, while maintaining significant operational activities in the United States, particularly in California and Oregon. U.S. operations focused on cannabis cultivation, extraction, manufacturing, and retail participation in regulated state markets.

Internationally, the company pursued cultivation and export-oriented investments in Lesotho, targeting access to medical cannabis markets in Europe and other international jurisdictions. Corporate materials also referenced strategic interest in broader international cannabis opportunities beyond North America. The extent of active international operations has varied over time based on restructuring activities, financing conditions, and changes in asset ownership disclosed in public filings.

Leadership & Governance

Halo Collective was founded by cannabis industry entrepreneurs involved in extraction and cannabis manufacturing operations during the company’s early development as Halo Labs. Leadership strategy historically emphasized vertical integration, international cultivation access, and expansion through acquisitions and partnerships. Public company governance included executive leadership, a board of directors, and reporting obligations associated with Canadian securities regulators and OTC market participation.

Key executives and leadership figures identified in public filings and company disclosures during recent reporting periods included:

• Kiran Sidhu – Chief Executive Officer
• Katie Field – President and Director
• Dustin Leonhardt – Co-Founder and former executive leadership figure
• John “JT” Thomas – Former executive leadership role associated with operations and strategy
• Chris A. Miglino – Board leadership involvement during portions of the company’s public operations

Leadership composition changed multiple times during restructuring periods and corporate transitions. Certain executive appointments and board roles varied across reporting years, and some current governance information is inconclusive based on available public sources.